Year: 2023

BOUCHERVILLE, Quebec, Oct. 18, 2023 (GLOBE NEWSWIRE) — Colabor Group Inc. (TSX: GCL) (“Colabor” or the “Company”) reports its results for the third quarter ended September 9, 2023. Third Quarter 2023 Financial Highlights:Sales increased by 13.1% to $164.7 million, compared to $145.7 million for the corresponding period of 2022; Net earnings from continuing operations were $3.5 million compared to $2.8 million for the corresponding period of 2022; and Adjusted EBITDA(1) increased by 24.1% to $11.0 million from $8.9 million for the corresponding period of 2022 with an adjusted EBITDA(1) margin to 6.7% of sales compared to 6.1% of sales during the corresponding period of 2022.Table of Third Quarter 2023 Financial Highlights:Financial highlights 12 weeks 36 weeks(in thousands of dollars, except percentages, per share data...

Preliminary Financial Results and Other Matters for the Quarter and Nine Months Ended September 30, 2023:Significant Expense Item: During the three months ended September 30, 2023, the Company recorded expenses in Legal and Professional Fees totaling $904,000 related to training and implementation costs for its upcoming core systems conversion and professional fees to consultants engaged to support the Company in its transition of core and ancillary software and information technology systems. Liquidity: The Company had secured borrowing line availability at the FHLBank and Federal Reserve Bank of $1.1 billion and $440 million, respectively, at September 30, 2023. In addition, at September 30, 2023, the Company had unpledged securities with a market value totaling $555 million, which could be pledged as collateral for additional borrowing...

Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic optionsWESTMINSTER, Colo., Oct. 18, 2023 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported third quarter 2023 financial results and provided a corporate update. In April 2022, the Board of Directors established a Special Committee and, in May 2022, retained Ladenburg Thalmann & Co. Inc. (“Ladenburg”) to evaluate strategic options, including transactions involving a merger, sale of all or part of the Company’s assets, or other alternatives with the goal of maximizing stockholder value. The Company and Ladenburg have reviewed...

Chart 1Crown Castle International Corp.Chart 2Crown Castle International Corp.HOUSTON, Oct. 18, 2023 (GLOBE NEWSWIRE) — Crown Castle Inc. (NYSE: CCI) (“Crown Castle”) today reported results for the third quarter ended September 30, 2023 and issued its full year 2024 outlook, as reflected in the table below.  Full Year 2024   Full Year 2023(dollars in millions, except per share amounts)Current OutlookMidpoint(a) Midpoint GrowthRate Comparedto Previous YearOutlook   Current OutlookMidpoint(a)   Midpoint GrowthRate Comparedto Previous YearActualSite rental revenues $6,370 (2)%   $6,511 4%Net income (loss) $1,253 (15)%   $1,469 (12)%Net income (loss) per share—diluted $2.88 (15)%   $3.38 (12)%Adjusted EBITDA(b) $4,163 (6)%   $4,422 2%AFFO(b) $3,005 (8)%   $3,279 2%AFFO per share(b) $6.91 (8)%   $7.54 2%(a)   As...

    OMEGA FLEX, INC. (OFLX)    Nine Months Ended September 30,   Three Months Ended September 30,                       2023     2022     2023     2022                 Net Sales   $83,318,000   $94,670,000   $27,496,000   $31,629,000                                  Net Income attributable to Omega Flex, Inc.   $15,874,000   $17,441,000   $5,576,000   $6,540,000                                  Earnings Per Share – Basic and Diluted   $1.57   $1.73   $0.55   $0.65                                  Weighted Average Shares – Basic and Diluted     10,094,322     10,094,322     10,094,322     10,094,322                 EXTON, Pa., Oct. 18, 2023 (GLOBE NEWSWIRE) — Kevin R. Hoben, Chairman and CEO, announced that the Company’s Net Sales for the first nine months of 2023 and 2022 were...

Financial and Operating HighlightsNet loss attributable to common stockholders of $0.38 per share for the third quarter of 2023 as compared to net income of $0.11 per share for the same period in 2022. Reported funds from operations, or FFO, of $1.27 per share for the third quarter of 2023 as compared to $1.66 per share for the same period in 2022. Signed 50 Manhattan office leases covering 355,831 square feet in the third quarter of 2023 and 134 Manhattan office leases covering 1,271,262 square feet for the first nine months of 2023. The mark-to-market on signed Manhattan office leases was 3.8% lower for the third quarter and 0.4% lower for the first nine months of 2023 than the previous fully escalated rents on the same spaces. Same-store cash net operating income, or NOI, including the Company’s share of same-store cash NOI...

Call Scheduled for 5:00 pm ET on Thursday, November 9, 2023 NEW YORK, Oct. 18, 2023 (GLOBE NEWSWIRE) — Logan Ridge Finance Corporation (Nasdaq: LRFC) (“LRFC,” “Logan Ridge” or the “Company”) to release its financial results for the third quarter ended September 30, 2023 on Wednesday, November 8, 2023, after market close. The Company will host a conference call on Thursday, November 9, 2023 at 5:00 p.m. ET to discuss these results.By Phone: To access the call, please dial (646) 307-1963 approximately 10 minutes prior to the start of the conference call and use the conference ID 3976270.   A replay of this conference call will be available shortly after the live call through November 16th.   By Webcast: A live audio webcast of the conference call can be accessed via the Internet, on a listen-only basis at https://edge.media-server.com/mmc/p/vy93a7qf....